Dechra Pharmaceuticals PLC
DPHAY · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Market Cap | $8,355 | $6,183 | $5,434 | $5,780 |
| - Cash | $74 | $121 | $118 | $227 |
| + Debt | $505 | $329 | $319 | $355 |
| Enterprise Value | $8,785 | $6,392 | $5,634 | $5,908 |
| Revenue | $762 | $682 | $608 | $515 |
| % Growth | 11.7% | 12.1% | 18% | – |
| Gross Profit | $426 | $385 | $346 | $292 |
| % Margin | 56% | 56.4% | 56.9% | 56.6% |
| EBITDA | $87 | $179 | $162 | $131 |
| % Margin | 11.4% | 26.2% | 26.6% | 25.4% |
| Net Income | -$28 | $58 | $56 | $34 |
| % Margin | -3.7% | 8.5% | 9.1% | 6.6% |
| EPS Diluted | -0.24 | 0.53 | 0.51 | 0.33 |
| % Growth | -145.3% | 3.9% | 54.5% | – |
| Operating Cash Flow | $64 | $123 | $89 | $106 |
| Capital Expenditures | -$30 | -$78 | -$135 | -$49 |
| Free Cash Flow | $33 | $45 | -$46 | $57 |